METASTATIC NEUROENDOCRINE CARCINOMA
Clinical trials for METASTATIC NEUROENDOCRINE CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC NEUROENDOCRINE CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC NEUROENDOCRINE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Triple-Drug cocktail shows promise against Tough-to-Treat neuroendocrine tumors
Disease control OngoingThis study tested a combination of three drugs—cabozantinib (which blocks cancer cell growth), nivolumab, and ipilimumab (which help the immune system attack cancer)—in 17 people with a rare, fast-growing type of neuroendocrine cancer that had spread. The goal was to see if the c…
Matched conditions: METASTATIC NEUROENDOCRINE CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 09:58 UTC
-
New combo therapy shows promise for Tough-to-Treat cancers
Disease control OngoingThis study tests a combination of two drugs—nivolumab (an immunotherapy that helps the immune system attack cancer) and temozolomide (a chemotherapy that kills cancer cells)—in people with advanced small-cell lung cancer or neuroendocrine tumors that have come back or stopped res…
Matched conditions: METASTATIC NEUROENDOCRINE CARCINOMA
Phase: PHASE2 • Sponsor: Dwight Owen • Aim: Disease control
Last updated May 19, 2026 11:59 UTC